Content area

|
|

Sygdomsmekanismer og nye behandlingsmetoder ved migræne

Forfatter(e)
Jakob Møller Hansen & Messoud Ashina Dansk Hovedpinecenter, Neurologisk Klinik, Rigshospitalet-Glostrup Ugeskr Læger 2016;178:V07160507
Reference: 
Ugeskr Læger 2016;178:V07160507
Blad nummer: 
Sidetal: 
2-6
Basic mechanisms of migraine and new methods of treatment
Migraine is the most prevalent disabling neurological disorder. The management of patients with migraine has been hampered by lack of effective and well-tolerated acute and preventive therapies. Based on improved insights into the basic mechanisms of migraine, new and targeted treatments are currently undergoing large-scale testing. Among the most promising agents for migraine prevention are humanized antibodies against calcitonin gene-related peptide (CGRP) or the CGRP receptor. If proven effective, these new treatments may emerge to improve the lives of millions of individuals worldwide disabled by migraine.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Knud Raben-Pedersen | 21/09
6 kommentarer
af Peter Matzen | 21/09
1 Kommentar
af Finn Vallø Hansen | 21/09
1 Kommentar
af Johan Ludvig Reventlow | 19/09
2 kommentarer
af Andreas Gothardt Lundh | 17/09
1 Kommentar
af Bjørn Søeberg | 17/09
33 kommentarer
af Lene Annette Norberg | 15/09
5 kommentarer
af Søren Holm | 14/09
1 Kommentar